Recently, high levels of NF-κB have been observed in many cancers, including pancreatic cancer [13], lung cancer [14], colorectal cancer [15], breast cancer [16], melanoma [17], and multiple myeloma [18]. Here, NFKB1 is linked to breast carcinoma.